L, K., M, B., & L, D. (2002). Interferons beta-1a and beta-1b for treatment of multiple sclerosis. Lancet, 360(9343), 1428. https://doi.org/10.1016/s0140-6736(02)11384-5
Chicago Style (17th ed.) CitationL, Kappos, Benatar M, and Durelli L. "Interferons Beta-1a and Beta-1b for Treatment of Multiple Sclerosis." Lancet 360, no. 9343 (2002): 1428. https://doi.org/10.1016/s0140-6736(02)11384-5.
MLA (9th ed.) CitationL, Kappos, et al. "Interferons Beta-1a and Beta-1b for Treatment of Multiple Sclerosis." Lancet, vol. 360, no. 9343, 2002, p. 1428, https://doi.org/10.1016/s0140-6736(02)11384-5.
Warning: These citations may not always be 100% accurate.